Blocking the inhibitory effects of sialic acids with a sialic acid blocking glycomimetic (Box 1) in a B16-OVA mouse model revealed reduced tumor growth, enhanced tumor killing by ovalbumin specific CD8+ T cells and inhibition of metastasis (106, 107) (Figure 4C). Here, CD8A is linked to neoplasm.